ARTICLE | Clinical News
CG100 regulatory update
May 25, 2015 7:00 AM UTC
The European Commission granted Orphan Drug designation to CG100 from Therabron to prevent bronchopulmonary dysplasia (BPD). The recombinant human club cell 10kD protein (rhCC10) is in Phase II testin...